Fresenius Medical Care AG & Co. KGaA

FME.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FME.SW stands at 9.7B. In comparison, AEVS.SW has a market cap of 1.1B. Regarding current trading prices, FME.SW is priced at CHF 32.99, while AEVS.SW trades at CHF 13.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FME.SW currently has a P/E ratio of 10.78, whereas AEVS.SW's P/E ratio is -56.25. In terms of profitability, FME.SW's ROE is +0.03%, compared to AEVS.SW's ROE of -0.04%. Regarding short-term risk, FME.SW and AEVS.SW have similar daily volatility (0.00).Check AEVS.SW's competition here

FME.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FME.SW stands at 9.7B. In comparison, RHK.SW has a market cap of 796.3M. Regarding current trading prices, FME.SW is priced at CHF 32.99, while RHK.SW trades at CHF 26.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FME.SW currently has a P/E ratio of 10.78, whereas RHK.SW's P/E ratio is 71.23. In terms of profitability, FME.SW's ROE is +0.03%, compared to RHK.SW's ROE of +0.02%. Regarding short-term risk, FME.SW and RHK.SW have similar daily volatility (0.00).Check RHK.SW's competition here